Vlad Coric is CEO at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). They have made 18 open-market trades across 2 companies since 2017, most recently 2026-06-05.
CIK 0001704317
10 open-market purchases totalling $44.3M since 2019, against 8 sales. Across 10 scored buys the stock is up 35.3% at ninety days, and 30.5 points ahead of the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| MANE | 182,500 | $19.9M |
| BHVN | 1,811,398 | $19.6M |
| RPRX | 15,343 | $935K |
| RVNC | 15,000 | $55K |
| Total | $40.4M |
Shares reported on the most recent Form 4, priced at the 2026-06-08 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 70% | 70% | 80% |
| Avg Move | +5.2% | +10.0% | +35.3% |
| Alpha | +4.2% | +7.3% | +30.5% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MANE | BUY | 2026-02-05 | 2026-02-05 | $17.00 | $1000K | +35.4% | +38.7% | +197.4% |
| BHVN | BUY | 2025-11-13 | 2025-11-17 | $7.50 | $5.0M | +21.6% | +31.8% | +39.2% |
| BHVN | BUY | 2024-10-02 | 2024-10-03 | $47.50 | $1000K | +9.1% | +7.7% | -19.8% |
| BHVN | BUY | 2024-04-22 | 2024-04-23 | $41.00 | $5.0M | +1.2% | -9.2% | -9.3% |
| BHVN | BUY | 2023-10-05 | 2023-10-10 | $22.00 | $10.0M | +3.4% | +4.3% | +77.7% |
| BHVN | BUY | 2022-10-31 | 2022-11-01 | $15.97 | $412K | -4.2% | -2.7% | +9.4% |
| BHVN | BUY | 2022-10-28 | 2022-10-31 | $14.84 | $2.7M | -6.6% | -6.2% | +10.1% |
| BHVN | BUY | 2022-10-25 | 2022-10-26 | $10.50 | $9.0M | +12.2% | +13.4% | +34.0% |
| BHVN | BUY | 2022-10-05 | 2022-10-06 | $10.31 | $10.0M | -21.6% | +17.4% | +9.7% |
| BHVN | BUY | 2019-06-26 | 2019-06-26 | $40.22 | $201K | +1.2% | +4.5% | +5.1% |
| BHVN | SELL | 2019-03-14 | 2019-03-14 | $50.02 | $1.6M | +5.2% | +19.2% | +24.4% |
| BHVN | SELL | 2019-03-13 | 2019-03-14 | $50.02 | $808K | +5.2% | +19.2% | +24.4% |
| BHVN | SELL | 2019-03-12 | 2019-03-14 | $50.15 | $2.6M | +5.2% | +19.2% | +24.4% |
| BHVN | SELL | 2019-03-12 | 2019-03-14 | $50.09 | $5.0M | +5.2% | +19.2% | +24.4% |
| BHVN | SELL | 2018-05-30 | 2018-06-01 | $35.02 | $3.4M | +10.2% | +17.8% | +8.2% |
| BHVN | SELL | 2017-11-01 | 2017-11-02 | $29.24 | $731K | -15.5% | -26.6% | +19.7% |
| BHVN | SELL | 2017-10-31 | 2017-11-02 | $29.47 | $2.9M | -15.5% | -26.6% | +19.7% |
| BHVN | SELL | 2017-10-31 | 2017-11-02 | $29.44 | $3.6M | -15.5% | -26.6% | +19.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.